283 related articles for article (PubMed ID: 16900525)
1. Phase II trial of pulse dactinomycin as salvage therapy for failed low-risk gestational trophoblastic neoplasia: a Gynecologic Oncology Group study.
Covens A; Filiaci VL; Burger RA; Osborne R; Chen MD;
Cancer; 2006 Sep; 107(6):1280-6. PubMed ID: 16900525
[TBL] [Abstract][Full Text] [Related]
2. Single-agent pulse dactinomycin has only modest activity for methotrexate-resistant gestational trophoblastic neoplasia.
Chen LM; Lengyel ER; Bethan Powell C
Gynecol Oncol; 2004 Jul; 94(1):204-7. PubMed ID: 15262143
[TBL] [Abstract][Full Text] [Related]
3. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
Homesley HD
J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
[TBL] [Abstract][Full Text] [Related]
4. [Effects of primary chemotherapy with single methotrexate on low-risk gestational trophoblastic neoplasia and influencing factors thereof].
Chen YX; Shen YM; Qian JH; Xie X
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2109-12. PubMed ID: 16313819
[TBL] [Abstract][Full Text] [Related]
5. Serum hCG level and rising world health organization score at second-line chemotherapy (pulse dactinomycin): poor prognostic factors for methotrexate-failed low-risk gestational trophoblastic neoplasia.
Kang WD; Kim CH; Cho MK; Kim JW; Cho HY; Kim YH; Choi HS; Kim SM
Int J Gynecol Cancer; 2010 Nov; 20(8):1424-8. PubMed ID: 21051988
[TBL] [Abstract][Full Text] [Related]
6. Comparison of pulse methotrexate and pulse dactinomycin in the treatment of low-risk gestational trophoblastic neoplasia.
Gilani MM; Yarandi F; Eftekhar Z; Hanjani P
Aust N Z J Obstet Gynaecol; 2005 Apr; 45(2):161-4. PubMed ID: 15760322
[TBL] [Abstract][Full Text] [Related]
7. Single-dose methotrexate regimen in the treatment of low-risk gestational trophoblastic neoplasia.
Chan KK; Huang Y; Tam KF; Tse KY; Ngan HY
Am J Obstet Gynecol; 2006 Nov; 195(5):1282-6. PubMed ID: 16723109
[TBL] [Abstract][Full Text] [Related]
8. [Combination chemotherapy with etoposide and cisplatin for high-risk, chemorefractory and recurrent gestational trophoblastic neoplasia].
Jiang J; Nan FF; Yang XS; Zhang YZ; Wang B; Kong BH
Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):595-9. PubMed ID: 17983513
[TBL] [Abstract][Full Text] [Related]
9. Weekly intramuscular methotrexate in the treatment of low-risk gestational trophoblastic neoplasia.
Mohit M; Sarraf Z; Sheikhi G; Robati M; Vasheghani-Farahani A
Arch Gynecol Obstet; 2009 Nov; 280(5):775-80. PubMed ID: 19263063
[TBL] [Abstract][Full Text] [Related]
10. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
[TBL] [Abstract][Full Text] [Related]
11. Treatment for low-risk gestational trophoblastic disease: comparison of single-agent methotrexate, dactinomycin and combination regimens.
AbrĂ£o RA; de Andrade JM; Tiezzi DG; Marana HR; Candido dos Reis FJ; Clagnan WS
Gynecol Oncol; 2008 Jan; 108(1):149-53. PubMed ID: 17931696
[TBL] [Abstract][Full Text] [Related]
12. Weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease.
Homesley HD; Blessing JA; Rettenmaier M; Capizzi RL; Major FJ; Twiggs LB
Obstet Gynecol; 1988 Sep; 72(3 Pt 1):413-8. PubMed ID: 2457192
[TBL] [Abstract][Full Text] [Related]
13. Secondary chemotherapy for high-risk gestational trophoblastic neoplasia.
Lurain JR; Nejad B
Gynecol Oncol; 2005 May; 97(2):618-23. PubMed ID: 15863169
[TBL] [Abstract][Full Text] [Related]
14. Management of low-risk gestational trophoblastic neoplasia in indigent women.
Schorge JO; Lea JS; Farrar DF; King MR; Coleman RL; Miller DS
J Reprod Med; 2003 Oct; 48(10):780-4. PubMed ID: 14628732
[TBL] [Abstract][Full Text] [Related]
15. High-risk gestational trophoblastic neoplasia with brain metastases: individualized multidisciplinary therapy in the management of four patients.
Soper JT; Spillman M; Sampson JH; Kirkpatrick JP; Wolf JK; Clarke-Pearson DL
Gynecol Oncol; 2007 Mar; 104(3):691-4. PubMed ID: 17137617
[TBL] [Abstract][Full Text] [Related]
16. Outcome of gestational trophoblastic neoplasia: experience from a tertiary cancer centre in India.
Gulia S; Bajpai J; Gupta S; Maheshwari A; Deodhar K; Kerkar RA; Seth V; Rekhi B; Menon S
Clin Oncol (R Coll Radiol); 2014 Jan; 26(1):39-44. PubMed ID: 24051171
[TBL] [Abstract][Full Text] [Related]
17. [Outcome of gestational trophoblastic neoplasia patients with residual lung tumor after completion of treatment].
Yang JJ; Xiang Y; Wan XR; Li JG; Yang XY
Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):26-8. PubMed ID: 17331417
[TBL] [Abstract][Full Text] [Related]
18. Low-risk gestational trophoblastic neoplasia and methotrexate resistance: predictors of response to treatment with actinomycin D and need for combination chemotherapy.
Growdon WB; Wolfberg AJ; Goldstein DP; Feltmate CM; Chinchilla ME; Lieberman ES; Berkowitz RS
J Reprod Med; 2010; 55(7-8):279-84. PubMed ID: 20795339
[TBL] [Abstract][Full Text] [Related]
19. Combined methotrexate-dactinomycin: an effective therapy for low-risk gestational trophoblastic neoplasia.
Eiriksson L; Wells T; Steed H; Schepansky A; Capstick V; Hoskins P; Pike J; Swenerton K
Gynecol Oncol; 2012 Mar; 124(3):553-7. PubMed ID: 22079360
[TBL] [Abstract][Full Text] [Related]
20. Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasia.
Growdon WB; Wolfberg AJ; Goldstein DP; Feltmate CM; Chinchilla ME; Lieberman ES; Berkowitz RS
Gynecol Oncol; 2009 Feb; 112(2):353-7. PubMed ID: 19059633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]